Authors
Loading...
Phase 2 trial shows TMLI-based allogeneic transplantation is feasible in young adults with acute lymphoblastic leukemia, indicating reduced toxicity.
Campos et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: